Akzo Nobel reports second-quarter results:
This article was originally published in Clinica
Executive Summary
Dutch chemicals and pharmaceutical company Akzo Nobel has reported sales of Fl 5,618 million ($3,300 million), up 4%, in the second quarter. Net income was down 4% to Fl 367 million. The pharmaceutical division's revenues rose 4% to Fl 996 million, and Organon Teknika, part of this division, suffered declining product volumes because of negative scientific reports on certain oral contraceptives during the period.